Health care stocks were advancing pre-bell Thursday as the iShares Biotechnology ETF (IBB) was marginally higher and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently.
ClearPoint Neuro (CLPT) shares were up nearly 10% after the company said the US Food and Drug Administration has granted De Novo marketing authorization for its SmartFlow Neuro Cannula for the delivery of PTC Therapeutics' Kebilidi gene therapy to targeted regions within the brain.
PTC Therapeutics (PTCT) shares were over 2% higher after the company said the US Food and Drug Administration has accelerated approval of Kebilidi, the company's gene therapy for aromatic L-amino acid decarboxylase deficiency.
BeiGene (BGNE) shares were 0.8% higher after the company said it plans to change its name to BeOne Medicines, subject to shareholder approval.
Comments